PENGARUH PEMBERIAN OBAT ANTIHIPERTENSI TERHADAP KUALITAS HIDUP PASIEN HIPERTENSI DENGAN GANGGUAN GINJAL KRONIK DI INSTALASI HEMODIALISA RSUP DR. HASAN SADIKIN BANDUNG

  • Anggun Hari Kusumawati
  • Lia Amalia
  • Rubin Surachno Gondodiputro
  • Cherry Rahayu

Abstract

ABSTRAK Hipertensi merupakan penyebab gangguan ginjal kronik melalui suatu proses yang mengakibatkan hilangnya sejumlah besar nefron fungsional yang progresif dan irreversible. The Kidney Disease Outcome Quality Initiative (K/DOQI) of the national kidney foundation (NKF) merekomendasikan target tekanan darah pada pasien gangguan ginjal kronik < 140/90 mmHg sehingga dapat mengurangi risiko terjadinya penyakit kardiovaskular. Penelitian ini bertujuan untuk mengetahui pengaruh pemberian obat antihipertensi terhadap kualitas hidup pasien GGK yang menjalani hemodialisis di RSUP DR.Hasan Sadikin Bandung. Penelitian menggunakan desain cross sectional observational konkuren dengan mengkaji data rekam medis dan status harian pasien selama periode Desember 2015-Febuari 2016 dan hasil pengisian kuisioner Kidney Disease and Quality of Life (KDQOLTM-36). Subyek penelitian merupakan pasien GGK yang menjalani hemodialisis dan mendapatkan terapi obat antihipertensi (OAH), laki-laki dan perempuan, usia lebih dari 18 tahun. Terdapat perbedaan bermakna penurunan tekanan darah sistolik(p=0,011) dan diastolik (p=0,023) untuk setiap terapi OAH, kombinasi 2 OAH memberikan efek penurunan tekanan darah sistolik dan diastolik yang paling baik dan berbeda bermakna (p=0,001). Pengobatan tunggal dan kombinasi dua obat antihipertensi memberikan efek penurunan tekanan darah yang paling baik.Setiap jenis terapi obat antihipertensi tidak memberikan perbedaan bermakna terhadap kualitas hidup kecuali domain aspek efek penyakit (p=0,041). Kata kunci : Hipertensi, gagal ginjal kronik, hemodialisis, antihipertensi, KDQOL, kualitas hidup. 40 ABSTRACT Background: Hypertension is the leading cause of chronic kidney disease (CKD) through a process that resulted in loss of a large number of functional nephron on progressive and irreversible. The Kidney Disease Outcome Quality Initiative (K/DOQI) of The National Kidney Foundation (NKF) recommends a target blood pressure values of < 130/80 mmHg in CKD patients, it can reduce the risk of cardiovascular disease. Objective : The purpose of this study is to understand the antihypertension medication effects to the quality of life of hemodialysis patients in RSUP DR.Hasan Sadikin Bandung. Methods : The design of study is cross sectional observational with concurrent medical record with patients daily status analyses during December 2015 - February 2016 with questionnaire by the Kidney Disease and Quality of Life (KDQOL-36. Results : The analysis result shows significant differences in the reduction of systolic (p=0, 011) and diastolic (p=0, 023) blood pressure in each group of antihypertension therapy. Furthermore, 2 combination of antihypertension therapy gives the most significant different in reduction of systolic and diastolic blood pressure (p=0, 001). Conclusions : Second combination of antihypertension therapy can be reduce of blood pressure better than other therapy. Second combinations of antihypertension therapy is best for decrease of blood pressure and creatinin serum. In all domain of quality of lifes, symptom/problems have a highest score, and burden of kidney disease have a lowest score of quality of life. Keywords : chronic kidney disease, hemodialysis, antihypertension, KDQOL, quality of life.

References

DAFTAR PUSTAKA 1. Collins AJ, Foley RN, Chavers B, et,.al, 2011. 'United States Renal Data System Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. American journal of kidney diseases: the official journal of the National Kidney Foundation; 59 (1 Suppl 1):A7, e1-420. Available from: Elsevier. 2. Fayers dan Machin. (2007): Quality of life: the assesment, analysis and interpretation of patient reported outcomes.Willey. 3. KDOQI, National Kidney F, 2009. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney disease. American journal of kidney diseases : the official journal of the National Kidney Foundation 47(5 Suppl 3):S11-145. Available from: Elsevier. 4. Lee,A., Gudex,C.,Povlsen, J.,Bonnevie, B., Nielsen,C. (2008): Patient’s views regarding choice of dialysis modality . Nephrology, dialysis transplantation : official publication of the European Dialysis and Transplant Association – European Renal Association. 23(12):3953-9. 5. Lopes A,A. (2002): Depression as a predictor of mortality and hospitalization among hemodialysis. Health and Quality of Life Outcome; 10(1):1-5. 6. Mapes, D.,Lopes,A., Sathayatum, Mc Cullough, Goodkin, Locatelli et al. (2003): Health relaty quality of life as a predictor of mortality and hospitalization : The dialisys outcomes and practice patterns study (DOPPS).Kidney Int.Jul 64(1):339-349. 7. Pernefri (Perkumpulan Nefrologi Indonesia). (2014) 7th Report of Indonesian Renal Registry. 8. Santos, et al. ( 2012): Quality of Life among women with sexual dysfunction undergoing hemodialysis. Health and Quality of life outcomes. 10(1):1-5. 9. Theolifou, P. (2013) Association of insomnia symtoms with kidney disease quality of life reported by patients on maintainances dialysis. Phsycology,

health and madicine 18(1);70-8.

Published
2017-06-13